Extracapillary glomerulonephritis during etanercept treatment for juvenile psoriatic arthritis

Clinical and Experimental Rheumatology

Volumn 28, Issue 1, 2010, Pages 91-93

  Menè, Paolo ^a   Franeta, Ana Jovana ^a   Conti, Giovanni ^b   Stoppacciaro, Antonella ^c   Chimenz, Roberto ^b   Fede, Antonio ^b   Gallizzi, Romina ^b   Fede, Carmelo ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Acute renal failure; Anti TNF ; Arthritis; Glomerulonephritis

Indexed keywords

CREATININE; CYANOCOBALAMIN; ETANERCEPT; FIBRINOGEN; FOLIC ACID; IRON; METHOTREXATE; METHYLPREDNISOLONE; NAPROXEN; PREDNISONE;

ACUTE KIDNEY FAILURE; ADOLESCENT; ANEMIA; ARTICLE; CASE REPORT; CELL INFILTRATION; CELL PROLIFERATION; CREATININE BLOOD LEVEL; DISEASE COURSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTRON MICROSCOPY; FEMALE; GLOMERULUS FILTRATION RATE; HEMATURIA; HUMAN; HYPERTENSION; IMMUNE COMPLEX NEPHRITIS; IRON THERAPY; JUVENILE RHEUMATOID ARTHRITIS; KIDNEY BIOPSY; KIDNEY DISEASE; MESANGIUM CELL; PODOCYTE; POLYARTHRITIS; PRIORITY JOURNAL; PROTEINURIA; PSORIASIS; PSORIATIC ARTHRITIS; SEVERE EXTRACAPILLARY CRESCENTIC PAUCIIMMUNE GLOMERULONEPHRITIS; URINALYSIS;

ADOLESCENT; ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; BIOPSY; FEMALE; GLOMERULONEPHRITIS; HUMANS; IMMUNOGLOBULIN G; KIDNEY FAILURE, ACUTE; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77949511829     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. QUARTIER P: When should we use TNF antagonists in children with rheumatic disease? Joint Bone Spine 2007; 74:1-3.
2. CHURCH LD, CHURCHMAN SM, HAWKINS PN, MCDERMOTT MF: Hereditary auto-inflammatory disorders and biologics. Springer Semin Immunopathol 2006, 27:94-508.
3. WONG M, ZIRING D, KORIN Y et al.: TNFalpha blockade in human diseases: mechanisms and future directions. Clin Immunol 2008; 126: 121-36.
4. KHANNA D, MCMAHON M, FURST DE: Safety of tumor necrosis factor-alpha antagonists. Drug Saf 2004; 27: 307-24.
5. JONSDOTTIR T, FORSLID J, VAN VOLLENHOVEN A et al.: Treatment with tumour necrosis factor alpha antagonists in patients with rheumatoid arthritis induces anticardiolipin antibodies. Ann Rheum Dis 2004; 63: 1075-8.
6. SHAKOOR N, MICHALSKA M, HARRIS CA, BLOCK JA: Drug-induced systemic lupus erythematosus associated with etanercept therapy. Lancet 2002; 359: 579-80.
7. DE BANDT M, SIBILIA J, LE LOET X et al.: Club Rheumatismes et Inflammation. Systemic lupus erythematosus induced by antitumour necrosis factor alpha therapy: a French national survey. Arthritis Res Ther 2005; 7: 545-51.
8. STOKES MB, FOSTER K, MARKOWITZ GS et al.: Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis. Nephrol Dial Transplant 2005; 20: 1400-6.
9. ICARDI A, ARAGHI P, CIABATTONI M, ROMANO U, LAZZARINI P, BIANCHI G: Kidney involvement in rheumatoid arthritis. Reumatismo 2003; 55: 76-85.
10. PETTY RE, SOUTHWOOD TR, MANNERS P et al., INTERNATIONAL LEAGUE OF ASSOCIATIONS FOR RHEUMATOLOGY: International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004; 31: 390-2.
11. DOULTON TWR, TUCKER B, REARDON J, VELASCO N: Antineutrophil cytoplasmic antibody-associated necrotizing crescentic glomerulonephritis in a patient receiving treatment with etanercept for severe rheumatoid arthritis. Clin Nephrol 2004; 62: 234-8
12. DEN BROEDER AA, ASSMANN KJ, VAN RIEL PL, WETZELS JF: Nephrotic syndrome as a complication of anti-TNFalpha in a patient with rheumatoid arthritis. Neth J Med 2003; 61: 137-41
13. KEMP E, NIELSEN H, PETERSEN LJ et al.: Newer immunomodulating drugs in rheumatoid arthritis may precipitate glomerulonephritis. Clin Nephrol 2001; 55: 87-8.
14. ROUX CH, BROCQ O, ALBERT C, BREUIL V, EULLER-ZIEGLER L: Cutaneous vasculitis and glomerulonephritis in a patient taking the anti-TNF alpha agent etanercept for rheumatoid arthritis. Joint Bone Spine 2004; 71: 444-5.
15. MOR A, BINGHAM C, BARISONI L, LYDON E, BELMONT HM: Proliferative lupus nephritis and leukocytoclastic vasculitis during treatment with etanercept. J Rheumatol 2005; 32: 740-3.
16. HELIN HJ, KORPELA MM, MUSTONEN JT et al.: Renal biopsy findings and clinico- pathological correlations in rheumatoid arthritis. Arthritis Rheum 1995; 38: 242-7.